Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
BMC Pediatr ; 19(1): 63, 2019 02 19.
Artículo en Inglés | MEDLINE | ID: mdl-30782170

RESUMEN

BACKGROUND: Primary lymphomas of the gastrointestinal tract are rare, accounting for only 1 to 4% of malignancies arising in the stomach, small intestine, or colon. The stomach is the most common extranodal site of lymphoma and gastric mucosa-associated lymphoid tissue (MALT) lymphoma accounts for 40% of primary gastric lymphoma. Gastric MALT lymphoma reaches its peak incidence between 50 to 60 years of age, therefore, it is rarely encountered in pediatric population. The presenting symptoms of gastric MALT lymphoma are usually nonspecific and primary perforation of gastric MALT lymphoma is uncommon. CASE PRESENTATION: A 12 year-old female presented with iron deficient anemia developed gastric perforation. Emergency laparoscopic repair of the perforation was performed and tissue pathology showed gastric MALT lymphoma infiltration. Helicobacter pylori eradication and radiotherapy were sequentially performed. Complete remission was achieved at two months after radiotherapy. To our best knowledge, she is the youngest patient with gastric MALT lymphoma reported in the literature. CONCLUSION: Iron deficient anemia is a common presenting manifestation of malignancies in adulthood. In pediatric population, iron deficient anemia is usually caused by nutritional deficient or blood loss. In this case report, we present a teenaged female without previous gastric ulcer history who presented with a rare gastric tumor and an uncommon primary perforation. Even if there is an uncertainty about the exact diagnosis prior to the surgery, the strategy of stomach-preserving therapy by laparoscopy for primary perforation was successful and provided a good quality of life.


Asunto(s)
Linfoma de Células B de la Zona Marginal/complicaciones , Perforación Espontánea/etiología , Gastropatías/etiología , Neoplasias Gástricas/complicaciones , Anemia Ferropénica/etiología , Antibacterianos/uso terapéutico , Niño , Femenino , Infecciones por Helicobacter/complicaciones , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Humanos , Laparoscopía , Linfoma de Células B de la Zona Marginal/radioterapia , Perforación Espontánea/cirugía , Gastropatías/cirugía , Neoplasias Gástricas/radioterapia
2.
J Pediatr Gastroenterol Nutr ; 60(5): 654-8, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25534776

RESUMEN

OBJECTIVES: Recurrent cholangitis may aggravate cholestatic liver cirrhosis in biliary atresia (BA) after the Kasai operation. This pilot study aimed to investigate whether Lactobacillus casei rhamnosus has the prophylactic efficacy for recurrent cholangitis in comparison with the conventional neomycin prophylaxis. METHODS: Twenty jaundice-free patients with BA ages 0 to 3 years who underwent a Kasai operation were enrolled and randomized into 2 groups with 10 patients each: neomycin (25 mg · kg · day for 4 days/wk) and L casei rhamnosus (8 × 10 colony-forming unit per day) groups. The treatment duration was 6 months. Bacterial stool cultures were performed before treatment and 1, 3, and 6 months after starting treatment. In addition, 10 patients with BA with similar status but without prophylaxis served as the historical control group. RESULTS: In the Lactobacillus group, 2 patients (20%, mean 0.03 ±â€Š0.07 episodes per month) developed cholangitis during the study period, with the same frequency as in the neomycin group and significantly lower than that in the control group (80%, P = 0.005, mean 0.22 ±â€Š0.16 episodes per month). The mean change in body weight z score during the 6 months in the Lactobacillus group was 0.97 ±â€Š0.59, which was significantly better than that in the control group (-0.01 ±â€Š0.79, P = 0.006). In bacterial stool cultures, the Lactobacillus and Escherichia coli populations significantly increased and decreased, respectively, in the Lactobacillus group. CONCLUSIONS: The use of L casei rhamnosus was as effective as neomycin in preventing cholangitis in patients with BA who underwent Kasai operation, and therefore could be considered as a potential alternative prophylactic regimen.


Asunto(s)
Atresia Biliar/cirugía , Colangitis/prevención & control , Lacticaseibacillus casei , Lacticaseibacillus rhamnosus , Probióticos/uso terapéutico , Antibacterianos/uso terapéutico , Peso Corporal , Colangitis/etiología , Supervivencia sin Enfermedad , Escherichia coli/aislamiento & purificación , Heces/microbiología , Femenino , Humanos , Lactante , Recién Nacido , Lactobacillus/aislamiento & purificación , Masculino , Neomicina/uso terapéutico , Proyectos Piloto , Portoenterostomía Hepática/efectos adversos , Recurrencia
3.
J Pediatr ; 160(3): 447-451.e1, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21924737

RESUMEN

OBJECTIVE: To identify the prevalence and risk factors of feeding and swallowing problems in patients with type II and type III spinal muscular atrophy (SMA). STUDY DESIGN: Cross-sectional data from 108 genetically confirmed patients with SMA (age range, 3-45 years; 60 with type II and 48 with type III) were analyzed. The questionnaire survey included demographic data, current motor function and respiratory status, feeding and swallowing difficulties, and consequences. The risk factors were analyzed via logistic regression. RESULTS: The 3 most common feeding and swallowing difficulties in patients with type II and III SMA were choking (30.6%), difficulty conveying food to the mouth (20.4%), and difficulty chewing (20.4%). Current motor function status was an independent risk factor for feeding and swallowing difficulties (sitters vs walkers: OR, 7.59; 95% CI, 1.22-47.46). All 4 nonsitters (ie, patients with type II SMA who had lost their sitting ability) had feeding and swallowing difficulties. Patients with feeding and swallowing difficulties had significantly higher rates of underweight and aspiration pneumonia than those without these problems. CONCLUSION: Patients with type II and III SMA have a high prevalence of risk factors for feeding and swallowing difficulties, suggesting that an individualized treatment plan should depend on current motor function status.


Asunto(s)
Trastornos de Deglución/etiología , Ingestión de Alimentos , Atrofias Musculares Espinales de la Infancia/fisiopatología , Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neumonía por Aspiración/etiología , Factores de Riesgo , Atrofias Musculares Espinales de la Infancia/complicaciones , Adulto Joven
4.
Children (Basel) ; 9(1)2022 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-35053695

RESUMEN

The common clinical manifestations of Meckel's diverticulum include painless lower gastrointestinal bleeding and intestinal obstruction due to intussusception. Intussusception induced by inverted Meckel's diverticulum has rarely been reported; furthermore, there is no report thus far of chronic nocturnal abdominal pain as a presenting symptom in children with Meckel's diverticulum. A 4-year-and-10-month-old girl with no significant history of previous illness presented with the sole complaint of chronic nocturnal abdominal pain for 3 months. The patient was reported to be asymptomatic during the day. A provisional diagnosis of chronic ileoileal intussusception was already under consideration in her previous hospital visits elsewhere. Physical examination revealed a soft, non-distended abdomen without tenderness. Imaging studies revealed ileoileal intussusception. Exploratory laparotomy showed ileoileal intussusception induced by an inverted Meckel's diverticulum with ulceration. The patient underwent successful surgery and made a full recovery. We report this case to remind physicians that Meckel's diverticulum should be considered in differential diagnosis of children presenting with the isolated symptom of chronic nocturnal abdominal pain.

5.
Pediatr Int ; 53(1): 18-23, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20557472

RESUMEN

BACKGROUND: Most infantile hypertrophic pyloric stenosis (IHPS) cases are diagnosed between 3 and 12 weeks after birth. Few data exist regarding Asian infants with IHPS who are younger than 3 weeks or are preterm. The goal of this study is to identify unusual clinical manifestations, clinical course, duration of hospital stay, and complications of Asian infants with IHPS who are preterm or younger than 3 weeks of age. METHODS: From 1991 to 2004, all IHPS patients admitted to three tertiary centers in southern Taiwan were enrolled. The clinical manifestations, duration of hospital stay and complications were further compared between the IHPS patients diagnosed before and after 3 weeks; preterm and term infants. RESULTS: A total of 214 patients were enrolled into the study; the mean age of diagnosis was 40 days of age; the average duration of hospital stay was 6.27 days. Eighteen (8.41%) patients were diagnosed before 3 weeks of age. A significantly shorter timeframe of diagnosis, a higher rate of jaundice, a lower daily body weight gain and longer duration of hospital stay were noted in the IHPS group prior to 3 weeks compared with those in IHPS group after 3 weeks. Eighteen were preterm infants. A significantly older age of symptom onset, a lower body weight at admission, more cases diagnosed by barium meal study and higher postoperative complication rates were noted in the preterm group versus full-term infants with IHPS. CONCLUSIONS: The IHPS cases diagnosed before 3 weeks of age had longer duration of hospital stay. Preterm infants with IHPS had more postoperative complications.


Asunto(s)
Enfermedades del Prematuro/diagnóstico , Estenosis Hipertrófica del Piloro/diagnóstico , Factores de Edad , Femenino , Humanos , Recién Nacido , Enfermedades del Prematuro/cirugía , Tiempo de Internación/estadística & datos numéricos , Masculino , Complicaciones Posoperatorias/epidemiología , Estenosis Hipertrófica del Piloro/complicaciones , Estenosis Hipertrófica del Piloro/cirugía , Estudios Retrospectivos , Taiwán
6.
J Int Med Res ; 49(9): 3000605211041509, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34510959

RESUMEN

Perivascular epithelioid cell tumour (PEComa) is an extremely rare neoplasm with distinctive morphology and specific expression of immunohistochemical markers. The lesion is typically diagnosed in middle-aged women, with few reports of paediatric cases, and there is no standardized treatment for the tumour type. Here, the case of a 17-year-old female, who presented with painless haematochezia for 2 days and was diagnosed with gastrointestinal PEComa of the sigmoid colon with regional lymph node metastasis after serial examination, is presented. She was treated by surgical resection of the tumour and cytotoxic chemotherapy comprising 900 mg/m2 gemcitabine and 100 mg/m2 docetaxel every 3 weeks for six cycles. Haematochezia did not recur, and complete response was achieved, with progression-free survival at the 24-month follow-up examination. Surgical resection with adjuvant conventional cytotoxic chemotherapy may be considered as an option for treating gastrointestinal PEComa.


Asunto(s)
Colon Sigmoide , Neoplasias de Células Epitelioides Perivasculares , Adolescente , Desoxicitidina/análogos & derivados , Docetaxel/uso terapéutico , Femenino , Humanos , Metástasis Linfática , Recurrencia Local de Neoplasia , Neoplasias de Células Epitelioides Perivasculares/tratamiento farmacológico , Neoplasias de Células Epitelioides Perivasculares/cirugía , Gemcitabina
7.
J Microbiol Immunol Infect ; 51(2): 166-173, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27590984

RESUMEN

BACKGROUND/PURPOSE: Viral infections and innate immunity signaling, especially Toll-like receptor 7 (TLR7) have been implicated in the pathogenesis of biliary atresia (BA). Administration of rhesus rotavirus-type A to newborn Balb/c mice produces inflammatory obstruction of bile ducts, which resembles human BA. However, whether activation of TLR7 signaling plays a role in neonatal hepatobiliary injury remains to be investigated. METHODS: TLR7 agonist, imiquimod (R837), was intraperitoneally administered to Balb/c mice within 24 hours of birth and then every other day. Morphological and histological injuries of liver and gallbladder were examined at 2 weeks. Hepatic messenger RNA expression of TLR7 signaling was studied. Terminal deoxynucleotidyl transferase 2'-deoxyuridine 5'-triphosphate nick end labeling staining was used to delineate hepatobiliary apoptosis upon TLR7 stimulation. RESULTS: TLR7 agonist, imiquimod, induced hypoplasia of the biliary system of neonatal Balb/c mice both in atrophic gallbladder and in paucity of intrahepatic bile ducts. There was significantly higher hepatic expression of TLR7 and downstream innate immunity-mediated interferon regulatory factor 7, interferon-α, and tumor necrosis factor-α. In addition, terminal deoxynucleotidyl transferase 2'-deoxyuridine 5'-triphosphate nick end labeling-positive cells in the liver were increased after injections of TLR7 agonist. CONCLUSION: The results demonstrate that TLR7 activation may trigger innate immunity pathways and induce apoptosis and hypoplasia of neonatal biliary trees in Balb/c mice. The novel findings give an implication of pathogenesis of infantile cholestasis, such as BA.


Asunto(s)
Atresia Biliar/patología , Sistema Biliar/patología , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Colestasis/patología , Vesícula Biliar/patología , Glicoproteínas de Membrana/agonistas , Glicoproteínas de Membrana/metabolismo , Receptor Toll-Like 7/agonistas , Receptor Toll-Like 7/metabolismo , Aminoquinolinas/farmacología , Animales , Apoptosis/fisiología , Atresia Biliar/inducido químicamente , ADN Nucleotidilexotransferasa/genética , Modelos Animales de Enfermedad , Imiquimod , Factor 7 Regulador del Interferón/metabolismo , Interferón-alfa/metabolismo , Glicoproteínas de Membrana/genética , Ratones , Ratones Endogámicos BALB C , ARN Mensajero/biosíntesis , Rotavirus/patogenicidad , Infecciones por Rotavirus/patología , Receptor Toll-Like 7/genética , Factor de Necrosis Tumoral alfa/metabolismo
10.
Skelet Muscle ; 5: 29, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26322222

RESUMEN

BACKGROUND: Transport protein particle (TRAPP) is a multiprotein complex involved in endoplasmic reticulum-to-Golgi trafficking. Zebrafish with a mutation in the TRAPPC11 orthologue showed hepatomegaly with steatosis and defects in visual system development. In humans, TRAPPC11 mutations have been reported in only three families showing limb-girdle muscular dystrophy (LGMD) or myopathy with movement disorders and intellectual disability. METHODS: We screened muscular dystrophy genes using next-generation sequencing and performed associated molecular and biochemical analyses in a patient with fatty liver and cataract in addition to infantile-onset muscle weakness. RESULTS: We identified the first Asian patient with TRAPPC11 mutations. Muscle pathology demonstrated typical dystrophic changes and liver biopsy revealed steatosis. The patient carried compound heterozygous mutations of a previously reported missense and a novel splice-site mutation. The splice-site change produced two aberrantly-spliced transcripts that were both predicted to result in translational frameshift and truncated proteins. Full-length TRAPPC11 protein was undetectable on immunoblotting. CONCLUSION: This report widens the phenotype of TRAPPC11-opathy as the patient showed the following: (1) congenital muscular dystrophy phenotype rather than LGMD; (2) steatosis and infantile-onset cataract, both not observed in previously reported patients; but (3) no ataxia or abnormal movement, clearly indicating that TRAPPC11 plays a physiological role in multiple tissues in human.

11.
Pediatr Infect Dis J ; 22(7): 584-8, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12867831

RESUMEN

BACKGROUND: The efficacy of hepatitis B immunoglobulin (HBIG) in infants of hepatitis B e antigen (HBeAg)-negative hepatitis B surface antigen (HBsAg) carrier mothers in Taiwan is not clear. OBJECTIVE: To describe the responses of infants born to HBeAg-negative carrier mothers receiving HBIG combined with hepatitis B vaccine. METHODS: Term babies born to HBeAg-negative carrier mothers were assigned based on chart number to 1 of the 2 treatment groups. Group A infants (n = 94) received 0.5 ml (145 IU) of HBIG within 24 h of birth and 3 subsequent doses of recombinant hepatitis B virus (HBV) vaccine at 3 to 5 days, 1 month and 6 months of age. Group B infants (n = 122) received 3 doses of vaccines only. Infants (n = 19) born to HBeAg-positive carrier mothers were treated like those in Group A and are referred to as Group C. Sera obtained from infants at 2 and 7 months of age were tested for hepatitis B virus (HBV) markers. RESULTS: There were 2 (1%; one in Group A and one in Group B) subclinical breakthrough hepatitis B infections among studied infants. One (5%) child of Group C had asymptomatic HBV infection at the age of 7 months and became a chronic carrier. The rate of protective anti-hepatitis B surface antibody (anti-HBs) titers achieved (>10 mIU/ml) by 2 months of age was significantly higher in Group A than that in Group B (98% vs. 57%, P < 0.001). However, it was not different by 7 months of age. Infants (Group A) immunized with HBIG and vaccine had a significantly higher geometric mean titer (GMT, milli-International Units/ml) of anti-HBs than those (Group B) with vaccines only at 2 months of age (P < 0.001). Conversely at 7 months of age, the GMT of anti-HBs was significantly higher in infants who received vaccine only (P = 0.001). CONCLUSIONS: A protective level of antibodies was achieved earlier in those infants receiving both passive and active immunizations. However, infants receiving active immunizations alone achieved a higher GMT at 7 months of age. There was no clear benefit of passive-active vs.active immunization alone for chronic HBV infection in infants of HBsAg-positive, HBeAg-negative mothers.


Asunto(s)
Portador Sano/inmunología , Vacunas contra Hepatitis B/administración & dosificación , Hepatitis B/tratamiento farmacológico , Inmunoglobulinas/administración & dosificación , Complicaciones Infecciosas del Embarazo/inmunología , Estudios de Casos y Controles , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Estudios de Seguimiento , Hepatitis B/congénito , Hepatitis B/inmunología , Antígenos e de la Hepatitis B/análisis , Antígenos e de la Hepatitis B/inmunología , Humanos , Recién Nacido , Masculino , Embarazo , Complicaciones Infecciosas del Embarazo/prevención & control , Resultado del Embarazo , Probabilidad , Estudios Prospectivos , Medición de Riesgo , Pruebas Serológicas , Estadísticas no Paramétricas , Taiwán , Resultado del Tratamiento
12.
J Formos Med Assoc ; 102(6): 424-8, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12923597

RESUMEN

Congenital chloride diarrhea (CLD) is a rare autosomal recessive disease characterized by persistent, lifelong, watery diarrhea with high fecal chloride concentration. It results from a defect of the bicarbonate/chloride exchange system in the distal ileum and colon. Polyhydramnios, premature birth, ileus without meconium passage, hypochloremia, and hyponatremia are typical features of CLD in the neonate, followed by chronic metabolic alkalosis, hypokalemia, hypochloremia, retarded growth, and renal impairment in older children and adults if the disease is not adequately treated. The diagnosis of CLD is highly dependent on the alertness of physicians. Prompt recognition and adequate replacement of fecal loss of chloride, sodium, potassium, and water are mandatory for satisfactory disease outcome. We report a case of CLD complicated with recurrent episodes of ileus, metabolic alkalosis, and hypokalemia causing frequent hospitalization in a 4-year-old boy. Normalized electrolytes and gasometric parameters, decreased abdominal circumference, and growth catch-up were achieved after education of the parents about daily care, and provision of adequate fluid and electrolyte supplementation.


Asunto(s)
Cloruros/metabolismo , Diarrea/congénito , Preescolar , Diagnóstico Diferencial , Diarrea/diagnóstico , Diarrea/metabolismo , Heces/química , Humanos , Masculino
13.
Neuromuscul Disord ; 23(4): 298-305, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23434070

RESUMEN

Contrary to the classical form, infantile facioscapulohumeral muscular dystrophy (FSHD) usually denotes a severe phenotype and is frequently associated with extramuscular involvements. To elucidate the genotype-phenotype correlation in this severe subgroup, we identified a cohort of nine patients with infantile FSHD who also carried a very short (10-13kb) EcoRI fragment. Their current age ranged from 8 to 33 years and age of onset ranged from 0.4 to 5 years. One patient even manifested his first FSHD-related symptoms at as early as 5 months of age, including inability to smile, poor response to call, and infantile spasms. To date, four patients were wheelchair-bound and six patients had asymmetric weakness. Sensorineural hearing loss and abnormal fundoscopic findings were observed in eight and all of patients respectively. Three with the smallest EcoRI fragments (10-11kb, with normal length being 50-300kb) had mental retardation. Two of these had epilepsy. Cardiac arrhythmias were found in five patients. Restrictive ventilatory defects were observed in seven patients, with one progressing to chronic respiratory failure. Two had swallowing difficulties; one of these required gastrostomy. We identified several rarely reported phenotypes in infantile FSHD, including cardiac arrhythmia, respiratory insufficiency, and swallowing difficulties. There seems to be a correlation between the severity of phenotype and the very short EcoRI fragment in the chromosome 4q35 region. We conclude that the high frequency of multi-organ involvements in this severe FSHD variant suggests the need for an early and multidisciplinary intervention.


Asunto(s)
Cromosomas Humanos Par 4 , Distrofia Muscular Facioescapulohumeral/fisiopatología , Adolescente , Adulto , Southern Blotting , Niño , Estudios de Cohortes , Desoxirribonucleasa EcoRI , Epilepsia/etiología , Epilepsia/genética , Femenino , Eliminación de Gen , Estudios de Asociación Genética , Pérdida Auditiva Sensorineural/etiología , Pérdida Auditiva Sensorineural/genética , Bloqueo Cardíaco/etiología , Bloqueo Cardíaco/genética , Humanos , Discapacidad Intelectual/etiología , Discapacidad Intelectual/genética , Masculino , Distrofia Muscular Facioescapulohumeral/complicaciones , Distrofia Muscular Facioescapulohumeral/genética , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Adulto Joven
15.
Pediatr Neonatol ; 52(4): 203-7, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21835365

RESUMEN

BACKGROUND: To study the influence of clinical audit on diagnosis, complications, and factors contributing to hospitalization of patients with infantile hypertrophic pyloric stenosis. STUDY DESIGN: Retrospective cohort study. METHOD: There were 214 patients from 1991 to 2004 from three medical centers in Kaohsiung. Data were analyzed with respect to diagnostic methods, complications, and factors requiring patient hospitalization. RESULTS: The ratio of male to female was 4.8:1 (177 males and 37 females). The diagnoses before admission were as follows: 22% had milk intolerance and 14.5% had esophageal reflux. There was a significant increase in the use of sonogram diagnostic test (p=0.005) and a decrease in the incidence of diagnosis by olive mass palpation but not by barium meal test. Surgery time of 48 hours after admission was significant with barium meal examination and related to longer hospital stay (p<0.001). Weight gain less than 800 g before admission (n=125) was related to longer hospital stay (p=0.026). CONCLUSION: The diagnostic method was changed from olive mass palpation to sonogram. Weight gain less than 800 g before admission and surgery time of 48 hours after admission were related to longer hospital stay.


Asunto(s)
Tiempo de Internación , Estenosis Pilórica/cirugía , Estudios de Cohortes , Femenino , Humanos , Hipertrofia , Lactante , Recién Nacido , Masculino , Estenosis Pilórica/complicaciones , Estenosis Pilórica/diagnóstico por imagen , Estudios Retrospectivos , Ultrasonografía
16.
Pediatrics ; 128(3): e530-6, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21873702

RESUMEN

OBJECTIVES: The pathogenesis of biliary atresia (BA) is unclear, but epidemiological studies may help to elucidate possible causes. The goals of this study were to identify BA incidence changes in Taiwan in 2004-2009 and to survey the factors that might influence incidence changes to elucidate the possible causes of BA. METHODS: A Taiwan national registry system for BA has been established since 2004. By using data from the national registry system for BA, we identified BA incidence changes in 2004-2009. We also evaluated the correlations between BA incidences and estimated rotavirus vaccine coverage rates and between BA incidences and the gross domestic product. RESULTS: A total of 185 patients with BA were identified in 2004-2009 in Taiwan, whereas the number of live births was 1 221 189. Compared with the incidence of BA in 2004-2006 (1.79 cases per 10,000 live births), the incidence of BA in 2007-2009 (1.23 cases per 10,000 live births) was decreased significantly (P = .01). BA incidences were negatively correlated with the gross domestic product (P = .02) and marginally negatively correlated with rotavirus vaccine coverage rates (P = .07). CONCLUSIONS: A significant decrease in BA incidence in Taiwan since 2007 has been noted and may be related to improvements in the general socioeconomic status and the popularity of rotavirus vaccination. Although more evidence is needed to establish a direct correlation, this phenomenon may shed light on possible causes of and preventive interventions for BA.


Asunto(s)
Atresia Biliar/epidemiología , Atresia Biliar/diagnóstico por imagen , Atresia Biliar/etnología , Atresia Biliar/prevención & control , Colangiografía , Femenino , Producto Interno Bruto , Humanos , Incidencia , Recién Nacido , Masculino , Vacunas contra Rotavirus , Clase Social , Taiwán/epidemiología
18.
Surg Laparosc Endosc Percutan Tech ; 20(1): e34-7, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20173608

RESUMEN

Aberrant congenital bands are a rare cause of acute intestinal obstruction and usually present a diagnostic challenge. In 2008, the authors encountered 2 children with acute terminal ileal herniation. In the first case, it was caused by a mesodiverticular band, and numerous freely hanging filmy membranes attached to the antimesenteric side of the small intestine were found concurrently; whereas, an anomalous band from the distal ileum to the cecum was the leading cause in the second case. The vascularity of both herniated intestines was not compromised, and laparoscopy was successfully carried out 84 and 93 hours after the onset of the symptoms, respectively. Instead of cohesive adhesions, both of the causes related to a single vascular band, and laparoscopy was an effective and safe tool in diagnosis and subsequent treatment. The case with a mesodiverticular band and filmy membranes is the first case report with incomplete regression of both the vitelline circulation and the ventral mesentery.


Asunto(s)
Síndrome de Bandas Amnióticas/complicaciones , Obstrucción Intestinal/etiología , Laparoscopía , Preescolar , Femenino , Humanos , Recién Nacido , Obstrucción Intestinal/cirugía , Masculino
20.
J Pediatr ; 148(5): 647-651, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16737879

RESUMEN

OBJECTIVE: To conduct a prospective cohort study to clarify the relationship between human leukocyte antigen (HLA) polymorphisms and the seroconversion of hepatitis B e antigen (HBeAg). STUDY DESIGN: In the prospective cohort study, 81 HBeAg-positive children with chronic hepatitis B virus (HBV) infection from 40 unrelated families were recruited and followed-up regularly for a mean period of 17.70 +/- 3.23 years. The association between HLA antigen and the age at HBeAg seroconversion was analyzed using Cox regression model with shared frailties under left truncation and right censorship. RESULTS: HLA-B61 and HLA-DQB1*0503 antigens predicted a higher HBeAg seroconversion rate (relative incidence = 6.17 and 3.22, P = .024 and .017, respectively). Within-family frailty in our sibling cohort study demonstrated a negligible or a low degree of within-family correlation with spontaneous HBeAg seroconversion in each HLA antigen. CONCLUSIONS: HLA class I antigen B61 and class II antigen DQB1*0503 are associated with earlier HBeAg seroconversion in Taiwanese children with chronic HBV infection.


Asunto(s)
Antígenos HLA-DQ/genética , Antígenos HLA-DR/genética , Antígenos e de la Hepatitis B/sangre , Hepatitis B Crónica/sangre , Hepatitis B Crónica/genética , Antígenos de Histocompatibilidad Clase I/sangre , Adolescente , Niño , Preescolar , Estudios de Cohortes , Femenino , Prueba de Histocompatibilidad , Humanos , Lactante , Recién Nacido , Masculino , Polimorfismo Genético/genética , Hermanos , Taiwán
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA